| Product Code: ETC7214900 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Carrier Screening Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Carrier Screening Market Revenues & Volume, 2021 & 2031F |
3.3 France Carrier Screening Market - Industry Life Cycle |
3.4 France Carrier Screening Market - Porter's Five Forces |
3.5 France Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 France Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 France Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.8 France Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 France Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 France Carrier Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic disorders and the importance of carrier screening |
4.2.2 Advancements in genetic testing technologies leading to more accurate and affordable screening options |
4.2.3 Rising prevalence of genetic disorders and birth defects in France |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for genetic testing and carrier screening |
4.3.2 Limited accessibility to carrier screening services in certain regions of France |
4.3.3 Lack of reimbursement policies for carrier screening tests by healthcare systems |
5 France Carrier Screening Market Trends |
6 France Carrier Screening Market, By Types |
6.1 France Carrier Screening Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 France Carrier Screening Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 France Carrier Screening Market Revenues & Volume, By Molecular Screening Test, 2021- 2031F |
6.1.4 France Carrier Screening Market Revenues & Volume, By Biochemical Screening Test, 2021- 2031F |
6.2 France Carrier Screening Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 France Carrier Screening Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.3 France Carrier Screening Market Revenues & Volume, By Tay-Sachs, 2021- 2031F |
6.2.4 France Carrier Screening Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.2.5 France Carrier Screening Market Revenues & Volume, By Sickle Cell Disease, 2021- 2031F |
6.2.6 France Carrier Screening Market Revenues & Volume, By Spinal Muscular Atrophy, 2021- 2031F |
6.2.7 France Carrier Screening Market Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021- 2031F |
6.3 France Carrier Screening Market, By Medical Condition |
6.3.1 Overview and Analysis |
6.3.2 France Carrier Screening Market Revenues & Volume, By Pulmonary Conditions, 2021- 2031F |
6.3.3 France Carrier Screening Market Revenues & Volume, By Hematological Conditions, 2021- 2031F |
6.3.4 France Carrier Screening Market Revenues & Volume, By Neurological Conditions, 2021- 2031F |
6.3.5 France Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.4 France Carrier Screening Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 France Carrier Screening Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.4.3 France Carrier Screening Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.4.4 France Carrier Screening Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.4.5 France Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.5 France Carrier Screening Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 France Carrier Screening Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 France Carrier Screening Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.5.4 France Carrier Screening Market Revenues & Volume, By Physician Offices and Clinics, 2021- 2031F |
6.5.5 France Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 France Carrier Screening Market Import-Export Trade Statistics |
7.1 France Carrier Screening Market Export to Major Countries |
7.2 France Carrier Screening Market Imports from Major Countries |
8 France Carrier Screening Market Key Performance Indicators |
8.1 Number of genetic counseling sessions conducted annually |
8.2 Adoption rate of next-generation sequencing technologies for carrier screening |
8.3 Percentage increase in the number of healthcare providers offering carrier screening services |
8.4 Average turnaround time for carrier screening test results |
8.5 Patient satisfaction scores related to carrier screening services provided |
9 France Carrier Screening Market - Opportunity Assessment |
9.1 France Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 France Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 France Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.4 France Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 France Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 France Carrier Screening Market - Competitive Landscape |
10.1 France Carrier Screening Market Revenue Share, By Companies, 2024 |
10.2 France Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here